Which has preferable valuation & earnings, WRBY or INMD?

InMode has lower revenue, but higher earnings than Warby Parker. InMode is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Warby Parker $890.57M 3.61 $1.64M $0.02 1,501.05 InMode $370.49M 2.29 $93.83M $1.36 10.84

Is WRBY or INMD more profitable?

InMode has a net margin of 23.27% compared to Warby Parker's net margin of 0.15%. InMode's return on equity of 13.47% beat Warby Parker's return on equity. Company Net Margins Return on Equity Return on Assets Warby Parker 0.15% 2.30% 1.18% InMode 23.27% 13.47% 11.95%

Does the media refer more to WRBY or INMD?

In the previous week, InMode had 1 more articles in the media than Warby Parker. MarketBeat recorded 8 mentions for InMode and 7 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.16 beat InMode's score of 0.59 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive InMode 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, TMDX or INMD?

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransMedics Group $635.89M 3.66 $190.29M $4.40 15.29 InMode $370.49M 2.29 $93.83M $1.36 10.84

Does the media refer more to TMDX or INMD?

In the previous week, InMode had 5 more articles in the media than TransMedics Group. MarketBeat recorded 8 mentions for InMode and 3 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.63 beat InMode's score of 0.59 indicating that TransMedics Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, ESTA or INMD?

InMode has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Establishment Labs $229.58M 11.21 -$51.06M -$1.49 N/A InMode $370.49M 2.29 $93.83M $1.36 10.84

Is ESTA or INMD more profitable?

InMode has a net margin of 23.27% compared to Establishment Labs' net margin of -19.05%. InMode's return on equity of 13.47% beat Establishment Labs' return on equity. Company Net Margins Return on Equity Return on Assets Establishment Labs -19.05% -218.77% -12.31% InMode 23.27% 13.47% 11.95%

Does the media refer more to ESTA or INMD?

In the previous week, InMode had 4 more articles in the media than Establishment Labs. MarketBeat recorded 8 mentions for InMode and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.66 beat InMode's score of 0.59 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, AXGN or INMD?

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AxoGen $225.21M 10.56 -$15.70M -$0.64 N/A InMode $370.49M 2.29 $93.83M $1.36 10.84

Is AXGN or INMD more profitable?

InMode has a net margin of 23.27% compared to AxoGen's net margin of -13.21%. InMode's return on equity of 13.47% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets AxoGen -13.21% -9.63% -6.26% InMode 23.27% 13.47% 11.95%

Does the media favor AXGN or INMD?

In the previous week, InMode had 5 more articles in the media than AxoGen. MarketBeat recorded 8 mentions for InMode and 3 mentions for AxoGen. AxoGen's average media sentiment score of 1.30 beat InMode's score of 0.59 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, BFLY or INMD?

InMode has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Butterfly Network $102.92M 22.14 -$77.06M -$0.30 N/A InMode $370.49M 2.29 $93.83M $1.36 10.84

Is BFLY or INMD more profitable?

InMode has a net margin of 23.27% compared to Butterfly Network's net margin of -73.63%. InMode's return on equity of 13.47% beat Butterfly Network's return on equity. Company Net Margins Return on Equity Return on Assets Butterfly Network -73.63% -34.41% -23.91% InMode 23.27% 13.47% 11.95%

Does the media favor BFLY or INMD?

In the previous week, Butterfly Network and Butterfly Network both had 8 articles in the media. InMode's average media sentiment score of 0.59 beat Butterfly Network's score of 0.29 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

InMode (INMD) Competitors

$14.74 +0.11 (+0.75%)

Closing price 06/29/2026 04:00 PM Eastern

Extended Trading

$14.74 -0.01 (-0.03%)

As of 06/29/2026 06:27 PM Eastern

Compare

INMD vs. WRBY, TMDX, ESTA, AXGN, and BFLY

Should you buy InMode stock or one of its competitors? MarketBeat compares InMode with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with InMode include Warby Parker (WRBY), TransMedics Group (TMDX), Establishment Labs (ESTA), AxoGen (AXGN), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

How does InMode compare to Warby Parker?

Warby Parker (NYSE:WRBY) and InMode (NASDAQ:INMD) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

InMode has a net margin of 23.27% compared to Warby Parker's net margin of 0.15%. InMode's return on equity of 13.47% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Warby Parker	0.15%	2.30%	1.18%
InMode	23.27%	13.47%	11.95%

Warby Parker presently has a consensus price target of $29.82, indicating a potential downside of 0.68%. InMode has a consensus price target of $16.00, indicating a potential upside of 8.55%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.67
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

InMode has lower revenue, but higher earnings than Warby Parker. InMode is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Warby Parker	$890.57M	3.61	$1.64M	$0.02	1,501.05
InMode	$370.49M	2.29	$93.83M	$1.36	10.84

Warby Parker has a beta of 1.96, indicating that its stock price is 96% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market.

In the previous week, InMode had 1 more articles in the media than Warby Parker. MarketBeat recorded 8 mentions for InMode and 7 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.16 beat InMode's score of 0.59 indicating that Warby Parker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Warby Parker	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats InMode on 9 of the 16 factors compared between the two stocks.

How does InMode compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 6.9% of TransMedics Group shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

TransMedics Group has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market.

In the previous week, InMode had 5 more articles in the media than TransMedics Group. MarketBeat recorded 8 mentions for InMode and 3 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.63 beat InMode's score of 0.59 indicating that TransMedics Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group presently has a consensus price target of $134.50, indicating a potential upside of 99.88%. InMode has a consensus price target of $16.00, indicating a potential upside of 8.55%. Given TransMedics Group's stronger consensus rating and higher probable upside, research analysts clearly believe TransMedics Group is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$635.89M	3.66	$190.29M	$4.40	15.29
InMode	$370.49M	2.29	$93.83M	$1.36	10.84

TransMedics Group has a net margin of 27.04% compared to InMode's net margin of 23.27%. TransMedics Group's return on equity of 22.38% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	27.04%	22.38%	8.46%
InMode	23.27%	13.47%	11.95%

Summary

TransMedics Group beats InMode on 12 of the 16 factors compared between the two stocks.

How does InMode compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, InMode had 4 more articles in the media than Establishment Labs. MarketBeat recorded 8 mentions for InMode and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.66 beat InMode's score of 0.59 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Establishment Labs currently has a consensus target price of $87.14, indicating a potential downside of 0.32%. InMode has a consensus target price of $16.00, indicating a potential upside of 8.55%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Establishment Labs has a beta of 1.11, indicating that its share price is 11% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, indicating that its share price is 94% more volatile than the broader market.

InMode has a net margin of 23.27% compared to Establishment Labs' net margin of -19.05%. InMode's return on equity of 13.47% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
InMode	23.27%	13.47%	11.95%

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

InMode has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$229.58M	11.21	-$51.06M	-$1.49	N/A
InMode	$370.49M	2.29	$93.83M	$1.36	10.84

Summary

InMode beats Establishment Labs on 10 of the 16 factors compared between the two stocks.

How does InMode compare to AxoGen?

AxoGen (NASDAQ:AXGN) and InMode (NASDAQ:INMD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

AxoGen currently has a consensus target price of $46.50, suggesting a potential upside of 3.98%. InMode has a consensus target price of $16.00, suggesting a potential upside of 8.55%. Given InMode's higher possible upside, analysts clearly believe InMode is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	10.56	-$15.70M	-$0.64	N/A
InMode	$370.49M	2.29	$93.83M	$1.36	10.84

InMode has a net margin of 23.27% compared to AxoGen's net margin of -13.21%. InMode's return on equity of 13.47% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.21%	-9.63%	-6.26%
InMode	23.27%	13.47%	11.95%

80.3% of AxoGen shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 2.4% of AxoGen shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, InMode had 5 more articles in the media than AxoGen. MarketBeat recorded 8 mentions for InMode and 3 mentions for AxoGen. AxoGen's average media sentiment score of 1.30 beat InMode's score of 0.59 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AxoGen has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market.

Summary

InMode beats AxoGen on 11 of the 16 factors compared between the two stocks.

How does InMode compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and InMode (NASDAQ:INMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, Butterfly Network and Butterfly Network both had 8 articles in the media. InMode's average media sentiment score of 0.59 beat Butterfly Network's score of 0.29 indicating that InMode is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	1 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Butterfly Network currently has a consensus target price of $5.56, suggesting a potential downside of 37.85%. InMode has a consensus target price of $16.00, suggesting a potential upside of 8.55%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$102.92M	22.14	-$77.06M	-$0.30	N/A
InMode	$370.49M	2.29	$93.83M	$1.36	10.84

InMode has a net margin of 23.27% compared to Butterfly Network's net margin of -73.63%. InMode's return on equity of 13.47% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-73.63%	-34.41%	-23.91%
InMode	23.27%	13.47%	11.95%

Butterfly Network has a beta of 2.22, suggesting that its stock price is 122% more volatile than the broader market. Comparatively, InMode has a beta of 1.94, suggesting that its stock price is 94% more volatile than the broader market.

37.8% of Butterfly Network shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 22.0% of Butterfly Network shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

InMode beats Butterfly Network on 10 of the 15 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INMD vs. The Competition

Export

Metric	InMode	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$840.94M	$8.70B	$6.85B	$12.20B
Dividend Yield	N/A	2.47%	2.66%	6.22%
P/E Ratio	10.84	16.26	26.02	24.36
Price / Sales	2.29	7.80	549.85	102.46
Price / Cash	9.81	18.07	29.09	36.93
Price / Book	1.37	3.46	10.98	6.49
Net Income	$93.83M	$226.25M	$3.57B	$336.61M
7 Day Performance	10.41%	3.06%	2.60%	1.25%
1 Month Performance	5.81%	-3.39%	0.93%	0.24%
1 Year Performance	2.08%	0.83%	36.40%	30.16%

InMode Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INMD InMode	1.5205 of 5 stars	$14.74 +0.8%	$16.00 +8.5%	+3.9%	$840.94M	$370.49M	10.84	480
WRBY Warby Parker	2.5611 of 5 stars	$26.95 +3.8%	$29.50 +9.4%	+37.1%	$2.78B	$871.91M	1,348.32	4,036	News Coverage Positive News Analyst Forecast Gap Up
TMDX TransMedics Group	4.2222 of 5 stars	$75.51 -4.2%	$134.50 +78.1%	-48.8%	$2.72B	$605.49M	17.16	210	Gap Up
ESTA Establishment Labs	1.3554 of 5 stars	$86.06 +1.5%	$87.14 +1.3%	+113.6%	$2.50B	$211.08M	N/A	1,004	Positive News Gap Down
AXGN AxoGen	1.9721 of 5 stars	$44.95 +0.2%	$46.50 +3.4%	+325.9%	$2.38B	$238.11M	N/A	450	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INMD) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InMode (INMD) Competitors

INMD vs. WRBY, TMDX, ESTA, AXGN, and BFLY

How does InMode compare to Warby Parker?

Summary

How does InMode compare to TransMedics Group?

Summary

How does InMode compare to Establishment Labs?

Summary

How does InMode compare to AxoGen?

Summary

How does InMode compare to Butterfly Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InMode (INMD) Competitors

INMD vs. WRBY, TMDX, ESTA, AXGN, and BFLY

How does InMode compare to Warby Parker?

Is WRBY or INMD more profitable?

Do analysts rate WRBY or INMD?

Do insiders & institutionals have more ownership in WRBY or INMD?

Which has preferable valuation & earnings, WRBY or INMD?

Which has more volatility & risk, WRBY or INMD?

Does the media refer more to WRBY or INMD?

Summary

How does InMode compare to TransMedics Group?

Do institutionals and insiders believe in TMDX or INMD?

Which has more volatility and risk, TMDX or INMD?

Does the media refer more to TMDX or INMD?

Do analysts prefer TMDX or INMD?

Which has higher earnings and valuation, TMDX or INMD?

Is TMDX or INMD more profitable?

Summary

How does InMode compare to Establishment Labs?

Does the media refer more to ESTA or INMD?

Do analysts recommend ESTA or INMD?

Which has more volatility & risk, ESTA or INMD?

Is ESTA or INMD more profitable?

Do insiders and institutionals believe in ESTA or INMD?

Which has stronger valuation and earnings, ESTA or INMD?

Summary

How does InMode compare to AxoGen?

Do analysts rate AXGN or INMD?

Which has better valuation and earnings, AXGN or INMD?

Is AXGN or INMD more profitable?

Do institutionals & insiders hold more shares of AXGN or INMD?

Does the media favor AXGN or INMD?

Which has more risk & volatility, AXGN or INMD?

Summary

How does InMode compare to Butterfly Network?

Does the media favor BFLY or INMD?

Do analysts rate BFLY or INMD?

Which has preferable earnings & valuation, BFLY or INMD?

Is BFLY or INMD more profitable?

Which has more risk and volatility, BFLY or INMD?

Do institutionals and insiders hold more shares of BFLY or INMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools